Published in World J Gastroenterol on November 07, 2008
Sequential expression of putative stem cell markers in gastric carcinogenesis. Br J Cancer (2011) 1.22
The hyaluronic acid receptor CD44 coordinates normal and metaplastic gastric epithelial progenitor cell proliferation. J Biol Chem (2013) 1.14
The Role of CD44 in the Pathogenesis, Diagnosis, and Therapy of Gastric Cancer. Gut Liver (2011) 1.11
Current molecular markers for gastric progenitor cells and gastric cancer stem cells. J Gastroenterol (2011) 1.05
Stem cells in gastric cancer. World J Gastroenterol (2015) 0.96
Non-coding RNAs and gastric cancer. World J Gastroenterol (2014) 0.96
CD44/CD24 expression in recurrent gastric cancer: a retrospective analysis. BMC Gastroenterol (2012) 0.92
Germline polymorphisms in genes involved in the CD44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinoma. Int J Cancer (2011) 0.92
Cancer Stem Cell Markers CD44, CD133 in Primary Gastric Adenocarcinoma. Int J Mol Cell Med (2014) 0.90
Gastric cancer stem cells: evidence, potential markers, and clinical implications. J Gastroenterol (2015) 0.87
Clinicopathologic significance of putative stem cell markers, CD44 and nestin, in gastric adenocarcinoma. Int J Clin Exp Pathol (2011) 0.82
CD44 but not CD24 expression is related to poor prognosis in non-cardia adenocarcinoma of the stomach. BMC Gastroenterol (2014) 0.82
Engineering of lipid prodrug-based, hyaluronic acid-decorated nanostructured lipid carriers platform for 5-fluorouracil and cisplatin combination gastric cancer therapy. Int J Nanomedicine (2015) 0.81
Aquaporin 3 promotes the stem-like properties of gastric cancer cells via Wnt/GSK-3β/β-catenin pathway. Oncotarget (2016) 0.80
Role of Sonic Hedgehog signaling during progression from inflammation to cancer in the stomach. World J Gastrointest Pathophysiol (2011) 0.78
CD44, Sonic Hedgehog, and Gli1 Expression Are Prognostic Biomarkers in Gastric Cancer Patients after Radical Resection. Gastroenterol Res Pract (2015) 0.78
Xiaotan Sanjie decoction inhibits interleukin-8-induced metastatic potency in gastric cancer. World J Gastroenterol (2015) 0.78
Low-dose interleukin-8 induces the adhesion, migration and invasion of the gastric cancer SGC-7901 cell line. Oncol Lett (2015) 0.77
Notch as a Driver of Gastric Epithelial Cell Proliferation. Cell Mol Gastroenterol Hepatol (2017) 0.75
Rapid and reliable detection of CD44 variants in gastric carcinoma using a nested reverse transcription-polymerase chain reaction. Oncol Lett (2015) 0.75
Clinicopathological and prognostic significance of cancer stem cell markers CD44 and CD133 in patients with gastric cancer: A comprehensive meta-analysis with 4729 patients involved. Medicine (Baltimore) (2016) 0.75
Postlactational involution biomarkers plasminogen and phospho-STAT3 are linked with active age-related lobular involution. Breast Cancer Res Treat (2017) 0.75
Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol (2001) 3.32
Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973-2000: increase in the signet ring cell type. Arch Pathol Lab Med (2004) 2.73
CD44 in cancer progression: adhesion, migration and growth regulation. J Mol Histol (2004) 2.71
A crucial role for CD44 in inflammation. Trends Mol Med (2001) 2.42
Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J Gastroenterol (2006) 1.82
Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res (1993) 1.68
The normal structure and function of CD44 and its role in neoplasia. Mol Pathol (1998) 1.44
Expression of CD44 abnormal transcripts in human gastric carcinomas. Cancer Lett (1994) 1.34
Cytogenetic and molecular aspects of gastric cancer: clinical implications. Cancer Lett (2008) 1.30
Gene deregulation in gastric cancer. Gene (2005) 1.28
CD44 and its partners in metastasis. Clin Exp Metastasis (2003) 1.27
Expression of CD44v6 in advanced gastric cancer and its relationship to hematogenous metastasis and long-term prognosis. J Surg Oncol (2002) 1.22
New aspects of Helicobacter pylori infection involvement in gastric oncogenesis. J Surg Res (2007) 1.19
Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer. World J Gastroenterol (2005) 1.14
Are CD44 variant isoforms involved in human tumour progression? Cancer Surv (1995) 1.10
p16 promoter hypermethylation: a useful serum marker for early detection of gastric cancer. World J Gastroenterol (2008) 1.07
Expression of heparanase gene, CD44v6, MMP-7 and nm23 protein and their relationship with the invasion and metastasis of gastric carcinomas. World J Gastroenterol (2004) 1.03
Expression of CD44 and its clinical implication in diffuse-type and intestinal-type gastric adenocarcinomas. Oncology (1995) 1.02
Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis. Anticancer Res (2003) 1.02
The expression and clinical significance of CD44v in human gastric cancers. World J Gastroenterol (2000) 0.97
Prognostic significance of CD44 and nm23 expression in patients with stage II and stage IIIA gastric carcinoma. J Surg Oncol (1999) 0.96
Molecular studies into the role of CD44 variants in metastasis in gastric cancer. Mol Pathol (1999) 0.94
Serum concentration of CD44 variant 6 and its relation to prognosis in patients with gastric carcinoma. Cancer (1998) 0.92
Epidemiology of upper gastrointestinal cancers in Iran: a sub site analysis of 761 cases. World J Gastroenterol (2007) 0.90
Prognostic evaluation of CD44 expression in correlation with bcl-2 and p53 in colorectal cancer. Folia Histochem Cytobiol (2005) 0.89
Importance of different CD44v6 expression in human gastric intestinal and diffuse type cancers for metastatic lymphogenic spreading. J Mol Med (Berl) (1995) 0.89
Expression of CD44 and its variant isoform v3 has no prognostic value in gastric cancer. Histopathology (2001) 0.87
CD44v6 in peripheral blood and bone marrow of patients with gastric cancer as micro-metastasis. World J Gastroenterol (2006) 0.83
Differential expression of CD44v6 in metastases of intestinal and diffuse types of gastric carcinoma. J Clin Pathol (1998) 0.83
Hereditary risk factors for the development of gastric cancer in younger patients. BMC Gastroenterol (2004) 0.80
A systematic review of aluminium phosphide poisoning. Arh Hig Rada Toksikol (2012) 2.93
Evaluation of the relationship between human epidermal growth factor receptor-2/neu (c-erbB-2) amplification and pathologic grading in patients with breast cancer. Saudi Med J (2006) 2.06
Intestinal alkaline phosphatase prevents metabolic syndrome in mice. Proc Natl Acad Sci U S A (2013) 1.89
The prevalence of hepatitis C virus in mashhad, iran: a population-based study. Hepat Mon (2013) 1.38
The prevalence of hepatitis B antigen-positivity in the general population of Mashhad, Iran. Hepat Mon (2011) 1.21
A pharmacological study on Berberis vulgaris fruit extract. J Ethnopharmacol (2005) 1.09
p16 promoter hypermethylation: a useful serum marker for early detection of gastric cancer. World J Gastroenterol (2008) 1.07
p16INK4a hypermethylation and p53, p16 and MDM2 protein expression in esophageal squamous cell carcinoma. BMC Cancer (2010) 1.06
Overexpression and interactions of interleukin-10, transforming growth factor beta, and vascular endothelial growth factor in esophageal squamous cell carcinoma. World J Surg (2009) 0.99
Intestinal alkaline phosphatase inhibits the proinflammatory nucleotide uridine diphosphate. Am J Physiol Gastrointest Liver Physiol (2013) 0.98
Association of p53/p21 expression with cigarette smoking and prognosis in esophageal squamous cell carcinoma patients. World J Gastroenterol (2010) 0.95
Stool-based DNA testing, a new noninvasive method for colorectal cancer screening, the first report from Iran. World J Gastroenterol (2007) 0.95
Soluble Fas might serve as a diagnostic tool for gastric adenocarcinoma. BMC Cancer (2010) 0.93
Cancer-testis gene expression profiling in esophageal squamous cell carcinoma: identification of specific tumor marker and potential targets for immunotherapy. Cancer Biol Ther (2011) 0.91
Aberrant p16 methylation, a possible epigenetic risk factor in familial esophageal squamous cell carcinoma. Int J Gastrointest Cancer (2005) 0.91
Primary bone lymphoma: a clinicopathological retrospective study of 28 patients in a single institution. J Res Med Sci (2011) 0.91
The antihypertensive and vasodilator effects of aqueous extract from Berberis vulgaris fruit on hypertensive rats. Phytother Res (2005) 0.90
Intestinal alkaline phosphatase prevents antibiotic-induced susceptibility to enteric pathogens. Ann Surg (2014) 0.88
Interactions between Glutathione-S-Transferase M1, T1 and P1 polymorphisms and smoking, and increased susceptibility to esophageal squamous cell carcinoma. Cancer Epidemiol (2010) 0.84
Comparison of pre-operative lymphoscintigraphy with inter-operative gamma probe and dye technique regarding the number of detected sentinel lymph nodes. Hell J Nucl Med (2009) 0.84
Role of hMLH1 and E-cadherin promoter methylation in gastric cancer progression. J Gastrointest Cancer (2014) 0.84
Quantitative analysis of TEM-8 and CEA tumor markers indicating free tumor cells in the peripheral blood of colorectal cancer patients. Int J Colorectal Dis (2011) 0.84
Primary gastrointestinal lymphoma. J Res Med Sci (2012) 0.83
INF- α and ototoxicity. Biomed Res Int (2013) 0.83
Immunohistochemical assessment of MGMT expression and p53 mutation in glioblastoma multiforme. Tumori (2011) 0.83
Expression analysis elucidates the roles of MAML1 and Twist1 in esophageal squamous cell carcinoma aggressiveness and metastasis. Ann Surg Oncol (2011) 0.82
Association between MGMT promoter hypermethylation and p53 mutation in glioblastoma. Cancer Invest (2009) 0.82
Clinicopathological significance of E-cadherin, β-catenin and p53 expression in gastric adenocarinoma. J Res Med Sci (2009) 0.80
Clinicopathological significance of macrophage migration inhibitory factor and its relation with p53 in gastric cancer. J Gastrointest Cancer (2011) 0.79
Two novel mutations in CYP11B1 and modeling the consequent alterations of the translated protein in classic congenital adrenal hyperplasia patients. Endocrine (2013) 0.79
Neoantigen in esophageal squamous cell carcinoma for dendritic cell-based cancer vaccine development. Med Oncol (2014) 0.78
Specific MUC1 splice variants are correlated with tumor progression in esophageal cancer. World J Surg (2014) 0.78
Induction of cytotoxic T lymphocytes primed with tumor RNA-loaded dendritic cells in esophageal squamous cell carcinoma: preliminary step for DC vaccine design. BMC Cancer (2010) 0.77
The efficacy of viscocanalostomy for uncontrollable primary open-angle glaucoma in a developing country. Indian J Ophthalmol (2013) 0.77
Influence of processing on the allergenic properties of pistachio nut assessed in vitro. J Agric Food Chem (2010) 0.77
Brain weight of Iranian population; the first report. J Forensic Leg Med (2010) 0.77
Serum chemokine ligand 5 (CCL5/RANTES) level might be utilized as a predictive marker of tumor behavior and disease prognosis in patients with gastric adenocarcinoma. J Gastrointest Cancer (2014) 0.76
Smell identification function in children with attention deficit hyperactivity disorder. Psychiatry Investig (2012) 0.75
Increased thickness of abdominal subcutaneous adipose tissue occurs more frequently in steatohepatitis than in simple steatosis. Arch Pathol Lab Med (2013) 0.75